BBT-877

· Bridge Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBT-877, covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF [Phase 2]